Early diagnosis and treatment of patients with infl uenza is the reason why physicians need rapid high-sensitivity infl uenza diagnostic tests that require no complex lab equipment and can be performed and interpreted within 15 min. The Aim of this study was to compare the rapid Directigen Flu A+B test with real time PCR for detection of infl uenza viruses in the Republic of Macedonia. MATERIALS AND METHODS: One-hundred-eight respiratory samples (combined nose and throat swabs) were routinely collected for detection of infl uenza virus during infl uenza seasons. Forty-one patients were pediatric cases and 59 were adult. Their mean age was 23 years. The patients were allocated into 6 age groups: 0 -4 yrs, 5 -9 yrs, 10 -14 yrs, 15 -19 yrs, 20-64 yrs and > 65 yrs. Each sample was tested with Directigen Flu A+B and CDC real time PCR kit for detection and typisation/subtypisation of infl uenza according to the lab diagnostic protocol. RESULTS: Directigen Flu A+B identifi ed infl uenza A virus in 20 (18.5%) samples and infl uenza B virus in two 2 (1.9%) samples. The high specifi city (100%) and PPV of Directigen Flu A+B we found in our study shows that the positive results do not need to be confi rmed. The overall sensitivity of Directigen Flu A+B is 35.1% for infl uenza A virus and 33.0% for infl uenza B virus. The sensitivity for infl uenza A is higher among children hospitalized (45.0%) and outpatients (40.0%) versus adults. CONCLU-SION: Directigen Flu A+B has relatively low sensitivity for detection of infl uenza viruses in combined nose and throat swabs. Negative results must be confi rmed.
INTRODUCTION
Infl uenza infections caused by the infl uenza A and B viruses are the most common respiratory infections. They can be self-limiting in healthy individuals. In very young (< 2 yrs), and elderly (> 65 yrs) individuals, people with co-morbidities such as chronic pulmonary, cardiovascular and metabolic disorders and immunocompromised individuals, infl uenza can be the cause for infl uenza-associated complications such as sinusitis, pharyngitis, bronchitis, pneumonia, croup and otitis media; prolonged hospitalization and mortality. 1, 2 Antiviral drugs are effective and well tolerated in a variety of low-and high-risk patients when used within the fi rst 48 h from onset of the diseases and prophylaxis of infl uenza. Many studies have demonstrated that early initiation of oral oseltamivir therapy increased its therapeutic effects reducing the duration of the symptoms, severity of the illness, incidence of secondary complications, and duration of the hospitalization. [3] [4] [5] Infl uenza can be diffi cult to diagnose based on clinical signs and symptoms alone because infl uenza illness can be similar to illness caused by other infectious agents including parainfl uenza viruses, adenovirus, respiratory syncytial virus and Legionella spp. 1, 2, 6 Timely diagnosis and treatment of patients with infl uenza is the reason why physicians need rapid infl uenza diagnostic tests with high sensitivity requiring no complex lab equipment and being able to be performed and interpreted easily within 15 minutes. [6] [7] [8] [9] 
AIM
The aim of this study was to compare the rapid Directigen Flu A+B test with real time PCR for detection of infl uenza viruses in the Republic of Macedonia.
MATERIALS AND METHODS
The samples included in this study were tested as part of a public health surveillance. The patients were informed about the need for taking samples and testing for infl uenza. The sampling procedure was performed after obtaining informed consent from the patients. The study was conducted in full conformity with the Helsinki declaration. The 108 respiratory samples that were routinely collected to detect infl uenza virus were nose and throat swabs taken during infl uenza seasons. They were placed immediately in a transport medium, kept at 2-8°C and transported to the laboratory as soon as possible. The nose and throat samples from each patient were combined in one single sample. Forty-one (37.9%) patients were pediatric cases (0-18 years old) and 59 (54.6%) were adult. Their mean age was 23 years (range 0-87 years). The patients were allocated into several age groups as follows: 0 -4 yrs (n = 16), 5 -9 yrs (n = 8), 10 -14 yrs (n = 8), 15 -19 yrs (n = 11), 20 -64 yrs (n = 54) and > 65 yrs (n = 3). The samples were taken from 87 (80.5%) hospitalized patients and from 21 (19.4%) outpatients.
RNA extraction was performed with QIAamp viral RNA kit (Qiagen, Germany) according to the manufacturer's instructions and used for real time PCR reaction for detection and typisation/ subtypisation of infl uenza virus. CDC real time RT-PCR was used with specifi c matrix and HA gene primers and probes for infl uenza virus typing and subtyping. The reaction was performed according to published laboratory diagnostic protocol (World Health Organization). CDC Protocol of rtRTPCR for swine infl uenza A (H1N1), 28 April 2009. The WHO Collaborating Centre for infl uenza at CDC Atlanta, United States of America). 10 fl uenza Surveillance Network (GISN). 11 The assay was performed on a IQ5 (Biorad). The turnaround time in real time machine is 2 hours.
The specimens were aliquot and stored at -70°C. They were tested with Directigen Flu A+B (Becton, Dickinson and Company, Maryland, USA).
Directigen Flu A+B is a membrane-based enzyme immunoassay for direct, simultaneous and qualitative detection of infl uenza A and B viral antigens. We performed it according to the instructions of the manufacturer. The sample was mixed with detergent and mucolytic agent and applied to the test membrane. After washing, the enzyme conjugated monoclonal antibody was added and the reactivity was determined by the appearance of a purple triangle on the membrane. A purple control dot only with no visible triangle indicates a negative test. The test took 15 minutes to perform.
The sensitivity, specifi city, positive predictive value (PPV) and negative predictive value (NPV) of the Directigen fl u A+B test results were calculated using results of the rRT-PCR assay as reference.
RESULTS
Out of the 108 samples tested with rRT-PCR, 72 (66.7%) were positive. Of these 57 (79.2%) were positive for infl uenza A virus and 15 (20.8%) for infl uenza B virus. From the infl uenza A positive samples 33 (57.9) were fl u A/H1pdm09, 8(14.0%) fl u A/H3 and 16 (28.1%) were not subtyped.
Out of 108 samples tested with Directigen Flu A+B, 20 (18.5%) samples were positive for infl uenza A and 2 (1.9) were positive for infl uenza B .
Test parameters of the Directigen Flu A+B test as compared with the rtRT-PCR (CDC) assay are shown in Tables 1, 2 and 3 by age groups.
DISCUSSION
Clinicians need fast, accurate and sensitive tests for detection of infl uenza virus in their daily routine work. Rapid tests are important for optimal timing of antiviral use, they eliminate the unnecessary prescription of antibiotics, and appropriate management of patients with infl uenza.
Real time RT-PCR is a method with high sensitivity (99.4%) and specifi city of diagnosing infl uenza virus infections, but it is too laborious and time consuming, requiring special complex laboratory infrastructure and equipment, and trained, highly skilled staff. It is not rapid and far from easy to perform if one has a low level of expertise. 12 Directigen Flu A+B is an easy rapid test taking only 15 minutes to perform. It does not require laboratory expertise and is able to be performed in the physician's offi ce.
When evaluating the performance of rapid tests it is important to consider the following factors related to specimen (type, quality and transport), patient (age and immune status) and infl uenza type. 6 According to the manufacturer specimens acceptable for infl uenza testing with Directigen Flu A+B are nasopharyngeal washes, nasopharyngeal aspirates, nasopharyngeal swabs, throat swabs, and bronchoalveolar lavages. We used nose and throat swabs as these are quite simple to take and can practically be collected in a physician's offi ce. 6 However, swab specimens are the least sensitive and the least specifi c in comparison with nasopharyngeal washes and aspirates due to higher viral loads in nasopharyngeal washes. 13 Manufacturer reports give sensitivity of 76.7% for infl uenza A and 0.00% for infl uenza B virus from combined nose/throat swabs compared with culture versus sensitivity of 95.7%/87.5% for infl uenza A and B, respectively when using nasopharyngeal aspirates. The sensitivity of the test when using throat swabs in pediatric cases is 79%, and in adult cases is 63%. The specifi city reported by the manufacturer is 90.8% for infl uenza A and 100% for infl uenza B from combined nose/throat swabs, and 91.4% -98.1% specifi city for infl uenza A -infl uenza B, respectively when using nasopharyngeal aspirates. (Leafl et provided by the manufacturer in the kit).
The high specifi city (100%) and PPV of the Directigen Flu A+B test observed in our study indicates that positive results can be the fi nal results allowing the physician to make a decisions for the treatment. That is comparable to previously published studies for rapid tests, including the Directigen Flu A+B. 5, 14, 15 The overall sensitivity of Directigen Flu A+B in the present study using combined nose and throat swabs is 48.5% for infl uenza A and 13.3% for infl uenza B which is lower than what has been found in other studies. In general, rapid tests show lower sensitivity than the sensitivity of PCR. 13, 14 Previous studies described variable low sensitivity ranging from 31.7% to 89% depending on the brand of rapid test. [14] [15] [16] [17] [18] [19] [20] The sensitivity of Directigen Flu A+B is higher in detecting infl uenza A versus infl uenza B virus which is a result consistent with the results in other studies. 21 Possible reasons is the higher number of samples positive for infl uenza A (57 samples) versus 15 infl uenza B positive samples included in the study.
Because the test is based on an antigen-antibody reaction with monoclonal antibodies specifi c for nucleoprotein (NP) with high homology in type A and B viruses, the sensitivity of the rapid test depends on the level of cross-reactivity of the NPspecifi c antibodies. 22 For infl uenza pandemics it is important to fi nd an assay able to detect infl uenza virus type A and a range of virus subtypes, particularly those with pandemic potential.
Among infl uenza A subtypes in our study better sensitivity was displayed in the detection of H1pdm09. This can be accounted for by the possible domination of Infl uenza A/H1pdm09 subtype in the infl uenza seasons and study group. However, due to a limited number of samples, the difference in sensitivity for H1N1pdm versus H3N2 did not reach statistical signifi cance. The test's sensitivity depends on time of collection during the illness and the type of sample. 23 The sensitivity for infl uenza A is higher among children hospitalized (45.0%) and outpatients (40.0%) especially among age groups 0-4 and 5-9 years, and was especially low in hospitalized and outpatient adults. Sensitivity is decreasing with age. 5, 20 The difference of the sensitivity between children and adults can be result of the longer virus shedding by the children. 24, 25 Also, children with infl uenza virus type A infections have higher viral loads in the nasopharynx than older patients. 21 The false negative results are possible at the early stage of infection when the virus load is relatively low and NP is insuffi cient to be detected with rapid test. Other reasons could be low quality of sample or a small number of studied patients. 22, 23 Negative tests can be the reason for delay in administration of antivirals which can lead to increased severity of infl uenza and likelihood of mortality. Negative result must be verifi ed.
We didn't confi rm the fi ndings in Chan et al. where the sensitivity, specifi city, PPV and NPV of the Directigen Flu A+B for infl uenza A were 96%, 99.6%, 96% and 99.6% and for infl uenza B these were 87.5%, 96.8%, 80% and 98%, respectively. 21 
LIMITATIONS OF THE STUDY
Specimen type affects rapid test performance, but we were not able to compare different specimens from one and the same patient. Multiple testing was not performed with individual samples. Most of the samples were kept frozen at -70°C for different time until the rapid test became available. In our study the samples were relatively few, as well as samples divided by age groups and type/subtype of the virus which can infl uence the results. These rises the need for larger sample size in further studies.
CONCLUSIONS
Our fi ndings indicates that the available rapid test in our lab for detection of infl uenza A and B -Directigen Flu A+B -has a relatively low sensitivity for detection of infl uenza viruses in combined throat and nose swabs. The low sensitivity indicates that it produces high false negative results. I this respect, negative results obtained with this test should be confi rmed with rtRT-PCR and clinicians should not rule out infl uenza, or change the decision for treatment based on a negative test result. There is a need to use more sensitive rapid test.
On the other hand, high specifi city of the Directigen Flu A+B test for detection of infl uenza A and B implies that physicians can consider the positive results fi nal and use them to plan further treatment.
